- Home
- BHVN vs ASTH Comparison
BHVN vs ASTH Comparison
Compare BHVN & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- ASTH
- Stock Information
- Founded
- BHVN 2013
- ASTH 1994
- Country
- BHVN United States
- ASTH United States
- Employees
- BHVN N/A
- ASTH N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- BHVN Health Care
- ASTH Consumer Discretionary
- Exchange
- BHVN Nasdaq
- ASTH Nasdaq
- Market Cap
- BHVN 1.5B
- ASTH 1.3B
- IPO Year
- BHVN 2017
- ASTH N/A
- Fundamental
- Price
- BHVN $14.72
- ASTH $29.08
- Analyst Decision
- BHVN Strong Buy
- ASTH Strong Buy
- Analyst Count
- BHVN 16
- ASTH 8
- Target Price
- BHVN $52.13
- ASTH $53.29
- AVG Volume (30 Days)
- BHVN 2.0M
- ASTH 333.2K
- Earning Date
- BHVN 11-11-2025
- ASTH 11-06-2025
- Dividend Yield
- BHVN N/A
- ASTH N/A
- EPS Growth
- BHVN N/A
- ASTH N/A
- EPS
- BHVN N/A
- ASTH 0.52
- Revenue
- BHVN N/A
- ASTH $2,419,115,000.00
- Revenue This Year
- BHVN N/A
- ASTH $60.77
- Revenue Next Year
- BHVN $2,195.07
- ASTH $26.90
- P/E Ratio
- BHVN N/A
- ASTH $56.27
- Revenue Growth
- BHVN N/A
- ASTH 51.97
- 52 Week Low
- BHVN $12.79
- ASTH $21.20
- 52 Week High
- BHVN $55.70
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- BHVN 49.97
- ASTH 49.52
- Support Level
- BHVN $13.41
- ASTH $28.48
- Resistance Level
- BHVN $14.23
- ASTH $30.58
- Average True Range (ATR)
- BHVN 0.86
- ASTH 1.21
- MACD
- BHVN -0.17
- ASTH -0.37
- Stochastic Oscillator
- BHVN 33.98
- ASTH 16.30
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.